Inherited Cancer Gene
Showing 26 - 50 of >10,000
Li-Fraumeni Syndrome, TP53 Gene Mutation, Hereditary Cancer Syndrome Trial in Boston (Data and Specimen Collection)
Recruiting
- Li-Fraumeni Syndrome
- +4 more
- Data and Specimen Collection
-
Boston, Massachusetts
- +2 more
Jan 23, 2023
FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR1 Gene Translocation Trial in United States (Pemigatinib, Quality-of-Life
Active, not recruiting
- FGFR1 Gene Amplification
- +18 more
- Pemigatinib
- Quality-of-Life Assessment
-
Scottsdale, Arizona
- +5 more
Oct 18, 2022
Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic
Recruiting
- Renal Tumor Histology
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 28, 2022
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Recruiting
- Xeroderma Pigmentosum
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Patients With a Constitutional Alteration of the PTEN Gene
Not yet recruiting
- PTEN Gene Mutation
- (no location specified)
Nov 17, 2022
Resectable Stage II-IIIB Driver Gene-negative Non-small Cell
Not yet recruiting
- NSCLC
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Aug 6, 2023
GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY
Not yet recruiting
- Salivary Gland Cancer
- Observation
- (no location specified)
Oct 13, 2023
Genetic Predisposition to Disease Trial in Paris, Cologne (BRIDGES gene panel testing, Breast cancer risk polygenic risk score
Completed
- Genetic Predisposition to Disease
- BRIDGES gene panel testing
- +2 more
-
Paris, France
- +1 more
Jan 19, 2023
Tumors From Inherited Cancers Having Had Two Surgeries
Completed
- Breast Cancer
- Ovarian Cancer
-
Seattle, WashingtonUniversity of Washington
Feb 2, 2022
Epithelial Ovarian Carcinoma, Pancreas Adenocarcinoma Trial in Boston, Danvers (Electronic Decision Aid, Pre-Test Genetic
Not yet recruiting
- Epithelial Ovarian Carcinoma
- Pancreas Adenocarcinoma
- Electronic Decision Aid
- Pre-Test Genetic Counseling
-
Boston, Massachusetts
- +1 more
Jul 20, 2022
Frequency of Occult Breast Cancer After Prophylactic Mastectomy
Recruiting
- Genetic Predisposition
- +3 more
- Histopathological confirmation
-
Karachi, Sindh, PakistanAga Khan University Hospital
Mar 15, 2023
Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)
Not yet recruiting
- Stem Cell Transplantation
- Fludarabine
- +9 more
-
Houston, TexasM D Anderson Cancer Center
May 4, 2022
Invasive Mammary Carcinoma, Metastatic Breast Cancer Trial in Nashville (Capecitabine, Endocrine-therapy, MammoPrint ® and
Not yet recruiting
- Invasive Mammary Carcinoma
- Metastatic Breast Cancer
- Capecitabine
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Jan 11, 2023
Cancer, Cancer Gene Mutation, PAN Gene Mutation Trial in Scottsdale, Jacksonville, Rochester (Pan-genomic Testing)
Not yet recruiting
- Cancer
- +2 more
- Pan-genomic Testing
-
Scottsdale, Arizona
- +2 more
Aug 18, 2023
BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome, Breast Ductal Carcinoma In Situ, Hematopoietic and Lymphoid
Recruiting
- BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
- +5 more
- Biospecimen Collection
- +3 more
-
Portland, Oregon
- +1 more
Feb 9, 2022
Profiling to Help Define Need for Neo-Adjuvant Chemotherapy in
Recruiting
- Breast Cancer
- GEP
-
Jette, Brussel, BelgiumUniversitair Ziekenhuis Brussel
Dec 16, 2022
NTRK Gene Fusion - Positive Advanced or Recurrent Solid
Recruiting
- Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
- Larotrectinib (Vitrakvi, BAY2757556)
-
Multiple Locations, JapanMany locations
Jan 20, 2023
ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,
Recruiting
- ATM Gene Mutation
- +16 more
- Niraparib
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 27, 2022
Results of Specific Gene Testing and Efficacy of Targeted
Completed
- Non Small Cell Lung Cancer
-
Changsha, Hunan, ChinaHunan Cancer hospital
Mar 27, 2023
NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)
Not yet recruiting
- Non-Small Cell Lung Cancer
- +3 more
- HMBD-001
- +3 more
-
Sydney, New South Wales, AustraliaGenesisCare North Shore
Jun 16, 2023
Gene Mutation-Related Cancer, Genetic Predisposition Trial (Genetic Information Assistant, Telegenetics with UVA genetic
Not yet recruiting
- Gene Mutation-Related Cancer
- Genetic Predisposition
- Genetic Information Assistant
- Telegenetics with UVA genetic counselor
- (no location specified)
Oct 17, 2023
GSTP1 and Other Gene Polymorphisms With Platinum-induced
Not yet recruiting
- Non-small Cell Lung Cancer
- GSTP1 A313G (AA)
- (no location specified)
Nov 16, 2023
Lung Cancer Trial in Boston, Nashville
Active, not recruiting
- Lung Cancer
-
Boston, Massachusetts
- +1 more
Dec 28, 2022
Subjects Previously Enrolled in Poxviral Vector Gene Transfer
Recruiting
- Prostate Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 19, 2022